| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0003-9861(54)90500-7 |
| P698 | PubMed publication ID | 13189588 |
| P2093 | author name string | T L SOURKES | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 444-456 | |
| P577 | publication date | 1954-08-01 | |
| P1433 | published in | Archives of Biochemistry and Biophysics | Q635818 |
| P1476 | title | Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine | |
| P478 | volume | 51 |
| Q48430077 | 18F fluoro-dopa: A unique gamma emitting substrate for Dopa decarboxylase |
| Q71176522 | 3, 4-Dihydroxyphenylalanine and Related Compounds |
| Q76476790 | A Hypothesis for the Mode of Action of α-Methyldopa in Relieving Hypertension |
| Q76458787 | A new inhibitor of decarboxylase of aromatic amino acids |
| Q41807738 | A study of potential histidine decarboxylase inhibitors |
| Q35440834 | ALPHA-METHYLDOPA IN THE TREATMENT OF HYPERTENSION. |
| Q59096115 | Actions of the Decarboxylase Inhibitor, α-Methyl-3,4-dihydroxyphenylalanine, in the Dog |
| Q42040312 | An investigation of transient intermediates in the reaction of 2-methylglutamate with glutamate decarboxylase from Escherichia coli |
| Q79373644 | Another hypotensive agent--methyldopa |
| Q38071275 | Antihypertensive drugs: clinical pharmacology and therapeutic use. |
| Q39131528 | Apomorphine: Chemistry, Pharmacology, Biochemistry |
| Q70345797 | Aromatic-L-amino acid decarboxylase |
| Q51301636 | Assay of 5-hydroxytryptophan decarboxylation in intact brain. |
| Q48631941 | Central nervous alpha-adrenergic receptors and the mode of action of alpha-methyldopa |
| Q59023595 | Chemical Transmission in the Central Nervous System |
| Q41767725 | Comparative metabolism of d-and l-3,4-dihydroxyphenylalanine in normal and pyridoxine-deficient rats |
| Q93745216 | Decarboxylase Activity and Methyldopa |
| Q78849316 | Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanine |
| Q67013330 | Decarboxylation-dependent transamination catalyzed by mammalian 3,4-dihydroxyphenylalanine decarboxylase |
| Q69223061 | Determination of alpha-alkyl-alpha-amino acids and alpha-amino alcohols by chiral-phase capillary gas chromatography and reverse-phase high-performance liquid chromatography |
| Q51251925 | EFFECT OF DENERVATION AND ENZYME INHIBITION ON DOPA DECARBOXYLASE AND MONOAMINE OXIDASE ACTIVITIES OF RAT PINEAL GLAND |
| Q78288121 | EXPERIENCES WITH THE LONG-TERM USE OF METHYLDOPA ("ALDOMET") IN HYPERTENSION |
| Q79032205 | Effect of Methyldopa in Carcinoid Disease |
| Q71909355 | Effects of ?-methyl-Dopa on conditioned behaviour in the cat |
| Q54702184 | Effects of Alpha‐Methyldopa on the Myocardial Blood Flow, Utilizing the Coincidence Counting Method |
| Q55635647 | Enhancement of Methyldopa Metabolism with Barbiturate |
| Q35250034 | Fundamental Structures in Drug Research |
| Q33600674 | GUANETHIDINE AND METHYLDOPA: A HAeMODYNAMIC STUDY |
| Q42055744 | HAeMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES |
| Q73503023 | How dopamine was recognised as a neurotransmitter: a personal view |
| Q79684025 | Hypotensive action methyldopa |
| Q78995506 | Inhibition of histidine decarboxylases and interaction of the inhibitors with pyridoxal 5′-phosphate |
| Q36840708 | Insensitivity of Bacteria to Proposed Antimetabolites of d -Alanyl- d -Alanine |
| Q51107835 | Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral Inhibitor |
| Q76508588 | MECHANISM OF THE CENTRAL STIMULANT ACTION OF ALPHA-METHYL-META-TYROSINE |
| Q46950749 | Mechanism of action of dopamine and other precursors of noradrenaline on the guinea-pig isolated hypogastric nerve vas deferens preparation |
| Q41844413 | Mechanism of the central hypotensive action of guanethidine |
| Q39922596 | Medical Management of Primary Hypertension |
| Q34449001 | Methyldopa |
| Q84947295 | Methyldopa |
| Q93745565 | Methyldopa and Depression |
| Q79378613 | Methyldopa in hypertension. Clinical and pharmacological studies |
| Q55444733 | Methyldopa in the Treatment of Hypertension. |
| Q79343779 | Methyldopa in the treatment of hypertension |
| Q67218875 | Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats |
| Q76847180 | NEW LOOK AT TOXAEMIA OF PREGNANCY |
| Q67283323 | New pathway for metabolism of dopa |
| Q40004118 | On the mode of action of l-dopa in Parkinson's disease |
| Q72240396 | Origin of urinary tyramine and trypta mine |
| Q76723993 | PHENOLIC ACID AND INDOLE EXCRETION IN URINE FOLLOWING ADMINISTRATION OF ALPHA-METHYLDOPA |
| Q55611143 | Parkinsonism occurring with methyldopa treatment. |
| Q48847165 | Possible New Metabolites mediating Actions of L-Dopa |
| Q46568294 | Potentiation of the central nervous system effects of DOPA by decarboxylase inhibition: Possible direct role of this neuroamino acid in brain mechanisms |
| Q48819885 | Relationships between pyridoxal phosphate availability, activity of vitamin B6-dependent enzymes and convulsions |
| Q48921700 | Some biochemical and pharmacological actions of α-methylphenylalanine |
| Q63344079 | Stereoselective synthesis of quaternary α-amino acids. Part 1: Acyclic compounds |
| Q72961921 | Studies on the physiology and physiopathology of the sympathico-adrenal system by determination of vanillin-mandelic acid excretion in the urine by thin-layer chromatography |
| Q42826756 | Studies on the relationship of 5-hydroxytryptamine and the enterochromaffin cell to anaphylactic shock in mice |
| Q39983792 | The biosynthesis and metabolism of the catecholamines |
| Q52576511 | The influence of endogenous dopamine levels on the density of [3H]SCH23390-binding sites in the brain of the honey bee, Apis mellifera L. |
| Q42401534 | The pharmacological actions of 3,4-dihydroxyphenyl-alpha-methylalanine (alpha-methyldopa), an inhibitor of 5-hydroxytryptophan decarboxylase |
| Q78827964 | The role of serotonin in neurobiology |
| Q79512594 | Treatment of severe hypertension with methyldopa |
| Q68624264 | [Synthesis, storage, and release of the adrenergic neurotransmitter] |
| Q79614651 | [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA] |
| Q48088190 | d-Tyrosine prevents hypertension in DOCA-saline treated uninephrectomised rats |
Search more.